Naganathan Girish 4
4 · DEXCOM INC · Filed Mar 10, 2023
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Naganathan Girish
EVP Chief Technology Officer
Transactions
- Award
Common Stock
2023-03-08$0.00/sh+18,776$19→ 50,225 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 50,225 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.